GAITHERSBURG, MD, September 30, 2021 – Adaptive Phage Therapeutics, Inc. (APT), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious…
Today, EDA announced that 50 organizations — including nonprofits, institutions of higher education, state government agencies, and other entrepreneurship-focused organizations…
September 28, 2021 RESTON, Virginia—During a year of unprecedented reliance on intellectual property rights to solve massive global challenges through…